Glucocorticoid receptor-binding characteristics in severe asthma

Bonnans C., Chanez P., Meziane H., Godard P., Bousquet J., Vachier I.

Source: Eur Respir J 2003; 21: 985-988
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Bonnans C., Chanez P., Meziane H., Godard P., Bousquet J., Vachier I.. Glucocorticoid receptor-binding characteristics in severe asthma. Eur Respir J 2003; 21: 985-988

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Formoterol enhances glucocorticoid receptor nuclear translocation in steroid-insensitive severe asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 250s
Year: 2004

The role of glucocorticoid receptor a and ß isoforms in exacerbations of asthma, COPD, and ACOS
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017


Corticosteroids: use and insensitivity in severe asthma
Source: Eur Respir Mon 2011; 51: 236-252
Year: 2011


Expression of the glucocorticoid β receptor in the sputum of moderate and severe asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 412s
Year: 2003

Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Rates of asthma exacerbations are not affected by beta2-adrenergic receptor genotype in patients with persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 708s
Year: 2005

Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003



Salmeterol response is not affected by beta2-adrenergic receptor genotype in patients with persistent asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 505s
Year: 2005

MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018

Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids
Source: Eur Respir J 2006; 27: 511-516
Year: 2006



Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

Reduced glucocorticoid receptor binding affinity in blood lymphocytes and monocytes of COPD patients
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018

Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma
Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Year: 2005


The glucocorticoid nuclear action peculiarities in the steroid-resistant patients with severe bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 32s
Year: 2003

Association of genetic variations of CC chemokine receptor-2 (CCR2) with atopic asthma, but not with nonatopic asthma
Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology
Year: 2005


Increased expression of ADRB2, CHRM3 and glucocorticoid alpha receptor genes in blood leukocytes of COPD patients
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016


Expression of glucocorticoid receptor beta (GCRβ) in asthmatic children and its correlation with clinical severity
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Corticosteroid insensitivity in severe asthma: Impaired nuclear translocation of glucocorticoid receptor in airway smooth muscle cells
Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways
Year: 2012


Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Effects of the novel toll-like receptor 7 (TLR7) agonist AZD8848 on allergen-induced responses in patients with mild asthma
Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD
Year: 2012